ClinicalTrials.gov record
Recruiting Phase 2 Interventional

CMV CTLs in Neonates With CMV Infection

ClinicalTrials.gov ID: NCT05564598

Public ClinicalTrials.gov record NCT05564598. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 12:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Open-Label Randomized Study of Anti-Viral Antibiotic Therapy With and Without Familial (Maternal) Cytomegalovirus (CMV) Cytotoxic T Lymphocytes (CTLs) in Neonates With Moderate/Severe Maternal Acquired CMV Infection

Study identification

NCT ID
NCT05564598
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
New York Medical College
Other
Enrollment
23 participants

Conditions and interventions

Interventions

  • Anti-viral Therapy Drug
  • CMV Cytotoxic T-Lymphocytes Biological

Drug · Biological

Eligibility (public fields only)

Age range
0 Days to 21 Days
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2023
Primary completion
Oct 30, 2027
Completion
Oct 30, 2028
Last update posted
Mar 29, 2026

2023 – 2028

United States locations

U.S. sites
4
U.S. states
4
U.S. cities
4
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027 Recruiting
Washington University St Louis Missouri 63130 Recruiting
New York Medical College Valhalla New York 10595 Recruiting
Nationwide Children's Hosptial Columbus Ohio 43205 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05564598, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05564598 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →